SCHEMBL4283966

SCHEMBL4283966

C=CC[Si](O)(CC=C)c1ccc(-c2ccc(OC)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.44
ALDH1A1 P00352 5/20 0.44
TP53 P04637 4/20 0.44
TSHR P16473 2/20 0.44
ALOX15 P16050 2/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX12 P18054 1/20 0.44
ESR2 Q92731 1/20 0.44
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MAPK1 P28482 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
HPGD P15428 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PKM P14618 1/20 0.40
KDM4E B2RXH2 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4272275 0.76 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1TP53TSHRALOX15
SCHEMBL2455996 0.75 NR1H2 (0.51) SMN1; SMN2ALDH1A1TP53TSHRALOX15
SCHEMBL132588 0.71 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1TP53TSHRALOX15
SCHEMBL4267425 0.71 NR1H2 (0.35)
SCHEMBL15302725 0.70 ALDH1A1 (0.34) ALDH1A1TSHRCYP3A4ESR2HPGD
SCHEMBL14007770 0.69 ESR2 (0.56) SMN1; SMN2TP53ESR2NPC1RAB9A
SCHEMBL11228368 0.69 ALDH1A1 (0.88) SMN1; SMN2ALDH1A1TP53TSHRALOX15
SCHEMBL19880405 0.69 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1TP53TSHRALOX15
SCHEMBL8576732 0.69 ALDH1A1 (0.88) SMN1; SMN2ALDH1A1TP53TSHRALOX15
SCHEMBL13657118 0.69 ESR2 (0.50) SMN1; SMN2TP53ESR2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7608673-B2 Organosilane compound and organosilica obtain therefrom KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2009-10-27 US disclosed
US-7608673-B2 Organosilane compound and organosilica obtain therefrom KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2009-10-27 US disclosed
US-20080227941-A1 Organosilane compound and organosilica obtained therefrom KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2008-09-18 US disclosed
US-20080227941-A1 Organosilane compound and organosilica obtained therefrom KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227941-A1 Organosilane compound and organosilica obtained therefrom OR51E2, WEE1, WEE2 SMN1; SMN2 4683/4885ALDH1A1 428/4885TP53 2369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.